Electrochemotherapy for Non-curable Gastric Cancer
NCT04139070 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2020-08-20
Summary
This is an explorative, phase I clinical trial. The aim of this study is to establish the safety and efficacy of electrochemotherapy for non-curable gastric cancer.
Conditions
Interventions
- DRUG
-
Bleomycin
Electroporation in combination with systemically administered bleomycin
Sponsors & Collaborators
-
Odense University Hospital
collaborator OTHER -
Zealand University Hospital
lead OTHER
Principal Investigators
-
ismail Gögenur, DMSc · Zealand University Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-15
- Primary Completion
- 2021-01-01
- Completion
- 2021-07-01
Countries
- Denmark
Study Locations
More Related Trials
-
Chemoprevention of Gastric Carcinogenesis
NCT02794428 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Adjuvant Chemotherapy for Gastric Cancer
NCT00296322 ·Status: COMPLETED ·Phase: PHASE3
-
Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
NCT04022109 ·Status: RECRUITING
-
The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer
NCT05000554 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
NCT01471470 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy for Patients With Cancer of the Stomach
NCT01928524 ·Status: COMPLETED ·Phase: PHASE1
-
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
NCT06727981 ·Status: RECRUITING
-
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
NCT06277453 ·Status: ACTIVE_NOT_RECRUITING
-
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
NCT00510107 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer
NCT01269255 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients
NCT01100801 ·Status: UNKNOWN ·Phase: PHASE2
-
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
NCT04220827 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Postoperative Chemoradiotherapy With S-1 in Gastric Cancer
NCT01824004 ·Status: COMPLETED ·Phase: PHASE2
-
Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer
NCT01756183 ·Status: UNKNOWN ·Phase: PHASE2
-
Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment
NCT02674373 ·Status: UNKNOWN
-
Postoperative Sequence Chemoradiotherapy Compared With Chemotherapy Alone for Advanced Gastric Cancer
NCT01197118 ·Status: UNKNOWN ·Phase: PHASE2
-
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
NCT06157216 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer
NCT04385641 ·Status: UNKNOWN ·Phase: NA
-
Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer
NCT01876927 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXP
NCT00976976 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
NCT05184803 ·Status: RECRUITING ·Phase: PHASE2
-
Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer
NCT03961373 ·Status: RECRUITING ·Phase: PHASE3
-
Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
NCT00165191 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer
NCT05334719 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer
NCT02215837 ·Status: UNKNOWN ·Phase: PHASE2